NEUE METHYLQUINAZOLINON-DERIVATE

European patent · EP4073065 · In force

Register entry

Publication number
EP4073065
Application number
EP20817377
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 8, 2020
Published
Oct 19, 2022
Granted
Feb 19, 2025
Protection ends at the latest
Dec 7, 2040
Next annual fee due
Dec 31, 2026
IPC classes
C07D 403/12 (2006.01)
A61P 35/00 (2006.01)
A61K 31/517 (2006.01)
Priority
EP 19214941 10.12.2019
PCT application
PCT/EP2020/084976 08.12.2020
PCT publication
WO2021/116055 17.06.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Dec 31, 2025

    Change

    Published in Swissreg on 31.12.2025

  3. Feb 19, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.02.2025

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

DOLENTE, Cosimo

4070 Basel

HEWINGS, David Stephen

4070 Basel

HUNZIKER, Daniel

4070 Basel

KRUMMENACHER, Daniela

4070 Basel

PETTAZZONI, Piergiorgio Francesco Tommaso

4070 Basel

WICHMANN, Juergen

4070 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.